Cancer immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized oncology but faces significant challenges from primary and acquired resistance.
This article provides a comprehensive analysis of tumor heterogeneity, a fundamental characteristic of cancer that drives progression and treatment resistance.
Exploring the retracted DDX11-AS1 study and the complex world of RNA interactions in gastric cancer biology
Exploring the groundbreaking extracorporeal ovary bioreactor system that could revolutionize fertility preservation for cancer patients and beyond.
Exploring the biological connection between Irritable Bowel Syndrome and Non-Alcoholic Fatty Liver Disease through the gut-liver-brain axis
Discover how amphibian egg jelly shows selective cytotoxicity against melanoma cells while sparing healthy cells, offering new hope in cancer treatment.
Explore the latest advances in biotechnology for treating hematological malignancies including menin inhibitors, protein degraders, and cutting-edge diagnostic tools.
Explore how computational and structural biotechnology is revolutionizing drug discovery, medical research, and our understanding of biological systems through AI, organ-on-a-chip technology, and advanced experimental design.
Explore CRISPR gene editing technology - how molecular scissors are revolutionizing medicine, treating genetic diseases, and rewriting the future of healthcare.
Discover how inflammation biomarkers in blood tests are revolutionizing lung cancer prognosis and treatment prediction.